Gland Pharma schedules Q2 FY26 earnings call for November 3

Gland Pharma will host an earnings conference call for investors and analysts on Monday, November 3, 2025, at 18:30 hours (IST). The 60-minute call will provide an opportunity for the management team to discuss the company's financial results and business developments for the quarter and half year concluded on September 30, 2025.

Interested participants can register for the call via a diamond pass link or use universal access numbers. International toll-free numbers are also provided for various regions, including USA (18667462133), UK (08081011573), Singapore (8001012045), and Hong Kong (800964448).

Following the call, an audio recording and transcript will be made available on Gland Pharma's official website. Sampath Kumar Pallerlamudi, company secretary & compliance officer, and Shriniwas Pradeep Dange, investor relations, are the contacts for further information.